Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine

被引:19
|
作者
Chen, Kuan-Chung [1 ]
Jian, Yi-Ru [2 ]
Sun, Mao-Feng [3 ,4 ]
Chang, Tung-Ti [3 ,5 ]
Lee, Cheng-Chun [6 ,7 ]
Chen, Calvin Yu-Chian [2 ,8 ,9 ,10 ,11 ]
机构
[1] China Med Univ, Grad Inst Pharmaceut Chem, Taichung 40402, Taiwan
[2] Asia Univ, Dept Biomed Informat, Taichung 41354, Taiwan
[3] China Med Univ, Sch Chinese Med, Taichung 40402, Taiwan
[4] China Med Univ Hosp, Dept Acupuncture, Taichung 40447, Taiwan
[5] China Med Univ Hosp, Div Chinese Pediat, Taichung 40447, Taiwan
[6] China Med Univ, Sch Med, Taichung 40402, Taiwan
[7] China Med Univ Hosp, Dept Neurol, Taichung 40447, Taiwan
[8] China Med Univ Hosp, Dept Med Res, Taichung 40447, Taiwan
[9] China Med Univ, Lab Computat & Syst Biol, Taichung 40402, Taiwan
[10] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan
[11] China Med Univ, Beigang Hosp, Dept Med Res, Yunlin 65152, Taiwan
来源
关键词
traditional Chinese medicine; docking; molecular dynamics; Sirt1; aging; MOLECULAR-DYNAMICS ANALYSIS; PROTEIN DEACETYLASES; TCM DATABASE; INHIBITORS; SIRTUINS; FAMILY; SIMULATION; DISEASE; MINIMIZATION; PERFORMANCE;
D O I
10.1080/07391102.2012.726191
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Silent information regulator 1 (Sirt1), a class III nicotinamide adenine dinucleotide dependent histone deacetylases, is important in cardioprotection, neuroprotection, metabolic disease, calorie restriction, and diseases associated with aging. Traditional Chinese Medicine (TCM) compounds from TCM Database@Taiwan (http://tcm.cmu.edu.tw/) were employed for screening potent Sirt1 agonists, and molecular dynamics (MD) simulation was implemented to simulate ligand optimum docking poses and protein structure under dynamic conditions. TCM compounds such as (S)-tryptophan-betaxanthin, 5-O-feruloylquinic acid, and RosA exhibited good binding affinity across different computational methods, and their drug-like potential were validated by MD simulation. Docking poses indicate that the carboxylic group of the three candidates generated H-bonds with residues in the protein chain from Ser441 to Lys444 and formed H-bond, -cation interactions, or hydrophobic contacts with Phe297 and key active residue, His363. During MD, stable -cation interactions with residues Phe273 or Arg274 were formed by (S)-tryptophan-betaxanthin and RosA. All candidates were anchored to His363 by stable - or H-bonds. Hence, we propose (S)-tryptophan-betaxanthin, 5-O-feruloylquinic acid, and RosA as potential lead compounds that can be further tested in drug development process for diseases associated with agingAn animated interactive 3D complement (I3DC) is available in Proteopedia at http://proteopedia.org/w/Journal:JBSD:28
引用
收藏
页码:1207 / 1218
页数:12
相关论文
共 50 条
  • [21] DBC1 is a negative regulator of SIRT1
    Ja-Eun Kim
    Junjie Chen
    Zhenkun Lou
    Nature, 2008, 451 : 583 - 586
  • [22] DBC1 is a negative regulator of SIRT1
    Kim, Ja-Eun
    Chen, Junjie
    Lou, Zhenkun
    NATURE, 2008, 451 (7178) : 583 - U10
  • [23] Metabolic benefits from Sirt1 and Sirt1 activators
    Chaudhary, Nilika
    Pfluger, Paul T.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2009, 12 (04): : 431 - 437
  • [24] Biochemical mechanism and biological effects of the inhibition of silent information regulator 1 (SIRT1) by EX-527 (SEN0014196 or selisistat)
    Broussy, Sylvain
    Laaroussi, Hanna
    Vidal, Michel
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 1124 - 1136
  • [25] Sildenafil protects against bile duct ligation induced hepatic fibrosis in rats: Potential role for silent information regulator 1 (SIRT1)
    Abd El Motteleb, Dalia M.
    Ibrahim, Islam A. A. E. -H.
    Elshazly, Shimaa M.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017, 335 : 64 - 71
  • [26] SIRT1, a promising regulator of bone homeostasis
    Chen, Ye
    Zhou, Feng
    Liu, Hanghang
    Li, Jiaxuan
    Che, Huiling
    Shen, Jiaqi
    Luo, En
    LIFE SCIENCES, 2021, 269
  • [27] SIRT1 as a regulator of cardiovascular oxidative stress
    Xia, N.
    Daiber, A.
    Habermeier, A.
    Spanier, G.
    Lu, Q.
    Oelze, M.
    Closs, E., I
    Muenzel, T.
    Foerstermann, U.
    Li, H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 21 - 22
  • [28] SIRT1: a novel regulator in colorectal cancer
    Dong, Weiwei
    Lu, Jinjing
    Li, You
    Zeng, Juan
    Du, Xiaoyun
    Yu, Ao
    Zhao, Xuechan
    Chi, Feng
    Xi, Zhuo
    Cao, Shuo
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 178
  • [29] SIRT1 is human fibroblasts lifespan regulator
    Blander, G.
    Matsui, M. S.
    Mammone, T.
    Guarente, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 81 - 81
  • [30] Differential Effects of HIV-1 Clade B and Clade C on the Expression of Silent Information Regulator2 Homolg-1 (SIRT1)
    Pichili, V. B.
    Nair, M. P. N.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 : S49 - S49